Xiaojie Wu

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance

Nannan Sun, Chuangpeng Shen, Lei Zhang et al. · Gut · 2020 · 125 citations · Full text

Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1

Bo Cheng, Weihang Gao, Xiaojie Wu et al. · Journal of Agricultural and Food Chemistry · 2020 · 59 citations

Lipid Peroxidation, Insulin Signaling, Oxidative Stress +16

Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects

Xiaofen Liu, Yuancheng Chen, Haijing Yang et al. · Journal of Infection · 2021 · 50 citations

Intravenous Polymyxin B, Health Sciences, Healthy Chinese Subjects +10

Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses

Beining Guo, Xiaojie Wu, Yingyuan Zhang et al. · Clinical Drug Investigation · 2012 · 42 citations

Medicine, Pharmacotherapy, Antimicrobial Pharmacokinetics +5

Development and validation of a UHPLC–MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction

Miao Zhao, Xiaojie Wu, Yaxin Fan et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 42 citations

Colistin Methanesulphonate, Separation Science, Medicine +14